GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannonau Corp (OTCPK:CNNC) » Definitions » ROE % Adjusted to Book Value

CNNC (Cannonau) ROE % Adjusted to Book Value : 0.00% (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Cannonau ROE % Adjusted to Book Value?

Cannonau's ROE % for the quarter that ended in Mar. 2024 was 0.00%. Cannonau's PB Ratio for the quarter that ended in Mar. 2024 was N/A. Cannonau's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was N/A.

Cannonau ROE % Adjusted to Book Value Historical Data

The historical data trend for Cannonau's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannonau ROE % Adjusted to Book Value Chart

Cannonau Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - Negative Equity

Cannonau Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - Negative Equity -

Competitive Comparison of Cannonau's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Cannonau's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannonau's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannonau's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Cannonau's ROE % Adjusted to Book Value falls into.


Cannonau ROE % Adjusted to Book Value Calculation

Cannonau's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=Negative Equity / N/A
=Negative Equity

Cannonau's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannonau ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Cannonau's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannonau Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannonau Corp (OTCPK:CNNC) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
CLVR EVOK JUVAF HENC STEK ECGS CPHI PTPI CLSH YCBD ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 XSWX:SDZ VTRS NBIX
Traded in Other Exchanges
N/A
Address
937 Old Seneca Turnpike Road, Skaneateles, NY, USA, 13252-9318
Website
http://www.cannonau.biz
Cannonau Corp is using cutting-edge nanotechnology plans to offer Cannabidiol (CBD) for improved bioavailability and maximum benefit. It believes that its formulas can be easily incorporated into a wide, offering customers an advantage when it counts.

Cannonau Headlines

From GuruFocus

Cannonau Corporation Announces New Medical Advisor

By ACCESSWIRE ACCESSWIRE • 05-18-2021

CANNONAU CORP. Submits Application For Uplisting To OTCQB

By ACCESSWIRE ACCESSWIRE • 03-08-2021

Cannonau Corporation Will Be Featured in The HempCBD Investor Magazine

By ACCESSWIRE ACCESSWIRE • 07-28-2021

Cannonau Corporation Signs Distribution Agreement with Virtual Medical International, Inc.

By ACCESSWIRE ACCESSWIRE • 05-06-2021

Cannonau Corporation Launches New CBD Website

By ACCESSWIRE ACCESSWIRE • 02-16-2021

Cannonau Corporation Announces New Cannabis Legal Advisor

By ACCESSWIRE ACCESSWIRE • 05-11-2021